SV Life Sciences Fund III (SVLSFIII)

SVLSF III closed in 2003 with total commitments of $393.2 million (plus $8.5 million of co-investments committed by partners and individuals affiliated with SVLS).

As at 31 December 2006 the Fund had invested $242million in 38 portfolio companies.

To go to individual portfolio companies websites please click on company logo.



Aquesys: US

First investment: 2006 - Early Stage

Develops a device treatment for primary open angle glaucoma using a soluble duct that functions to reduce intraocular pressure by creating a drainage pathway for excess fluid to flow from the anterior chamber into the sub conjunctiva.

---

Cellutions: US

First investment: 2004 - Seed

Minimally invasive treatment of cellulite.

---

CHF Solutions: US

First investment: 2005 - Expansion

Mechanical pump filter system to remove fluid from patients with congestive heart failure.

---

Concentric Medical: US

First investment: 2003 - Expansion

Interventional neurovascular products for stroke treatment.

---

EBR Systems: US

First investment: 2005 - Early Stage

EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management.

---

Entellus: US

First investment: 2006 - Early Stage

Entellus is focused on providing unique solutions to the unmet clinical needs of the ENT physician through the development of innovative device technology.

---

Eunoe: US

First investment: 2003 - Expansion

Treatment of neurological disorders through cerebrospinal fluid management (CSF).

---

Gyros: Sweden

First investment: 2002 - Start Up

Microfluidic tools for laboratory applications.

---

Insulet: US

First investment SVLSF II: 2001 - Start Up
First investment SVLSF III: 2004 - Expansion

Disposable insulin infusion devices for diabetes.

---

Liposonix: US

First investment SVLSF II: 2001 - Seed
First investment SVLSF III: 2003 - Seed

Focused ultrasound alternative to liposuction..

Funded through the innovation factory.

---

Neovista: US

First investment: 2003 - Seed

Developing a technology to irradiate the back of the eye for treatment of Wet AMD.

---

OsteoLign: US

First investment: 2005 - Seed

OsteoLign is an early stage company founded by The Innovation Factory with a minimally invasive solution for long bone fractures.

---

ReShape: US

First investment: 2005 - Seed

Concept-stage company developing a medical device based treatment for obesity. (Previously known as Abdominis, Inc).

---

Sadra Medical: US

First investment: 2003 - Seed

A company developing a medical device for the percutaneous replacement of aortic valves.

---

Spinal Kinetics: US

First investment: 2005 - Early Stage

Spinal Kinetics is a development stage company dedicated to providing innovative, therapeutic devices for the treatment of degenerative diseases of the spine.